MEDIOCON INC is a trusted manufacturer, exporter, and bulk supplier of Oblimersen Sodium API (Active Pharmaceutical Ingredient), offering premium pharmaceutical-grade raw material for formulation development, commercial pharmaceutical manufacturing, analytical testing, quality control laboratories, stability studies, and authorized pharmaceutical research applications. MEDIOCON INC manufactures Oblimersen Sodium API under stringent quality management systems to ensure exceptional purity, batch-to-batch consistency, and compliance with international pharmaceutical standards.
Oblimersen Sodium is a synthetic antisense oligonucleotide active pharmaceutical ingredient developed for oncology research and targeted therapeutic applications. It is designed to inhibit the expression of the BCL-2 protein, promoting apoptosis in cancer cells and enhancing the effectiveness of anticancer therapies. The API is extensively utilized in pharmaceutical research, formulation development, analytical method validation, process optimization, stability studies, and quality control applications. MEDIOCON INC supplies high-quality Oblimersen Sodium API that meets stringent pharmaceutical quality standards for domestic and international pharmaceutical markets.
Every production batch manufactured by MEDIOCON INC undergoes comprehensive quality testing including sequence identification, HPLC assay, impurity profiling, oligonucleotide purity determination, water content analysis, heavy metal testing, and other critical quality assessments. This rigorous quality assurance program ensures excellent pharmaceutical performance, product stability, and batch-to-batch consistency.
MEDIOCON INC supplies Oblimersen Sodium API to pharmaceutical manufacturers, biotechnology companies, contract manufacturing organizations (CMOs), oncology research laboratories, academic institutions, and distributors across domestic and international markets. We provide competitive pricing, dependable bulk supply, worldwide logistics support, and complete regulatory documentation including Certificate of Analysis (COA), Material Safety Data Sheet (MSDS), Technical Data Sheet (TDS), and supporting quality documents upon request.
Whether your organization requires Oblimersen Sodium API for oncology formulation development, analytical testing, validation studies, or pharmaceutical research, MEDIOCON INC is committed to delivering premium-quality pharmaceutical ingredients backed by professional technical support and reliable global supply.
| Parameter | Specification |
|---|---|
| Appearance | White to Off-White Lyophilized Powder |
| Identification | HPLC & Sequence Analysis Complies |
| Assay (HPLC) | ≥ 98.0% |
| Loss on Drying | NMT 5.0% |
| Residue on Ignition | NMT 1.0% |
| Heavy Metals | NMT 10 ppm |
| pH (1% Solution) | 6.5 – 8.5 |
| Individual Impurity | NMT 1.0% |
| Total Impurities | NMT 2.0% |
| Water Content | NMT 5.0% |
| Solubility | Freely Soluble in Water |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Oblimersen Sodium API Manufacturer & Bulk Supplier in India (CAS 174484-41-4) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Oblimersen Sodium API Manufacturer & Bulk Supplier in India is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing before release with a Certificate of Analysis.
Export Markets
Quality & Compliance